Skip to content

PTC Therapeutics PTCT Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$2.81M-100%$15.9M+115%-$64.85M+34.6%$866.56M+1,046%
$15.41M+113%$12.9M+90.7%$11.11M+71.3%$7.58M+8.1%$7.22M-87.0%
$23.42M+29.7%$18.52M+7.4%$19.43M-1.7%$18.54M-3.6%$18.06M-1.7%
-$59.04M-107%$870.1M+1,130%
$1.2M-30.6%$2.37M-37.0%$3.45M+560%$1.32M$1.72M-82.0%
-$93.74M+49.2%$0-100%-$289.62M-579%-$422.01M-540%-$184.36M-60.4%
$6.4M-32.0%$302.5M+1,043%$15.22M$3.96M-98.4%$9.41M+1,643%
-$147.9M-121%$312.03M+22.1%-$346.77M-169%$700.55M+1,634%
-$60.24M-107%$868.38M+1,320%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does PTC Therapeutics generate?
PTC Therapeutics (PTCT) generated $704.1M in operating cash flow over the trailing twelve months.
What is PTC Therapeutics's free cash flow?
After $8.3M of capital expenditures, PTC Therapeutics's free cash flow was $696.9M over the trailing twelve months, up 637.5% year over year.
Where does PTC Therapeutics's cash flow data come from?
Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.